醫藥和生物技術領域的聯合推廣和聯合行銷協議（2016-2026）

本報告是分析生命科學產業聯合商業化策略最全面的資源。報告包含 384 個詳細的案例研究，並提供公開合約的連結。這份經過全面修訂和更新的報告詳細揭示了該行業最重要的合作關係的合約條款、結構和策略。

無論您是在洽談新的合作關係，還是在評估現有合作關係，本報告都能提供數據驅動的洞察，幫助您建立更聰明、更強大、更獲利的協議。

您將從本報告中獲得：

• 取得 384 個真實案例：詳細了解合約結構、收益分成、地理劃分和商業化責任，並提供線上合約文件的連結（如有）。
• 了解成功的合約結構：了解生物製藥行業的領導者如何在聯合推廣和聯合行銷協議中劃分推廣活動、分配權利和管理獨家銷售權。
• 自信談判：利用詳細的財務數據（包括付款條款）來了解標準和可行的條件。
• 向業界領導者學習：研究輝瑞、諾華和阿斯特捷利康等公司如何進行聯合商業化。
• 查閱實際合約：審查實際合約（例如美國證券交易委員會 (SEC) 的文件），以了解新聞稿或資料庫中未揭露的交易機制。
• 了解市場趨勢：追蹤市場活動，包括依年份、治療領域、技術類型和公司（A-Z）劃分的趨勢。

目錄

摘要整理

第一章：引言

第二章：共同推廣與聯合行銷的趨勢

• 共同推廣與聯合行銷協議的定義
• 2016年以來的合約趨勢
  • 依年份劃分的合約趨勢
  • 依研發階段劃分的合約趨勢
  • 依行業劃分的合約趨勢
  • 依治療領域劃分的合約趨勢
  • 依技術類型劃分的合約趨勢
  • 最活躍的公司合約趨勢
• 簽訂合作協議的原因
• 共同推廣與聯合行銷的未來協議

第三章：聯合推廣與聯合行銷協議的架構：概述

• 共同推廣與聯合行銷協議的架構

第四章：主要聯合推廣與聯合行銷協議

• 主要共同推廣與聯合行銷交易：依金額排序

第五章：最活躍的25個聯合推廣與聯合行銷合約

• 最活躍的25個聯合推廣和聯合行銷合約

第六章：聯合推廣與聯合行銷協議（含合約目錄）

• 共同推廣與聯合行銷協議： 2016-2026
• 合約目錄
• 合約目錄：依公司（A-Z）
• 合約目錄：依治療領域
• 合約目錄：依技術
• 關於 Biopharma Research Ltd
• 當前合作夥伴關係
• 當前協議
• 近期合作報告標題

The Definitive Resource for Structuring and Benchmarking Shared Commercialization Partnerships

The Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2026 report provides the most comprehensive analysis available of co-commercialization strategies across the life sciences industry. Featuring 384 detailed deal records and links to publicly available contracts where filed, this fully revised and updated report gives you an unmatched look inside the terms, structures, and strategies behind the industry's most impactful partnerships.

Whether you're negotiating a new alliance or benchmarking existing agreements, this report gives you the data-driven insights you need to craft smarter, stronger, and more profitable deals.

What You'll Gain

• Access 384 Real-World Deals - Get the details on deal structure, revenue sharing, territory splits, and commercialization responsibilities, with links to online contract documents where available.
• Understand Winning Structures - See how biopharma leaders split promotional duties, allocate rights, and manage exclusivity across co-promotion and co-marketing agreements.
• Negotiate with Confidence - Leverage detailed financial data, including payment terms, to understand what's standard-and what's possible.
• Learn from the Leaders - Examine how top players like Pfizer, Novartis and AstraZeneca approach co-commercialization.
• Access Real Contracts - Where available, review actual SEC-filed agreements to understand deal mechanics that press releases and databases don't reveal.
• Stay Ahead of Market Trends - Track activity including trends by year, therapy area, technology type, and company A-Z.

Inside the Report - Chapter Overview

Chapter 1: Introduction

An orientation to the structure, purpose, and use of the report.

Chapter 2: Co-promotion and Co-marketing Trends

Covers key industry trends, growth in activity, and strategic rationale for shared commercialization models.

Chapter 3: Deal Structures and Terms

Explains how companies structure these partnerships-including revenue splits, territories, exclusivity, responsibilities, and duration.

Chapter 4: Top Deals by Value

A curated overview of high-value deals with direct links to online records and available SEC-filed contracts.

Chapter 5: Top 25 Most Active Dealmakers

Profiles of the most prolific companies in co-commercialization, each linked to their deal records and available contract documents.

Chapter 6: Deal Analysis by Company, Therapy & Tech

An in-depth review of all co-promotion and co-marketing deals signed since 2016, categorized by company A-Z, therapeutic area, technology type, and contract availability.

Deal Directory

A complete deal listing, each linked to a detailed record in the Current Agreements database, with direct access to contract documents where available.

What's Included

Industry trends in co-promotion and co-marketing (2016-2026)

Overview of deal structures and revenue models

Analysis of top deals and dealmakers

Directory of all deals by company, therapy area, and technology

Access to real contract documents (where publicly available)

Numerous tables and figures illustrating activity across the industry

Who Should Use This Report?

• Business Development & Licensing Teams - Evaluate deal structures and identify ideal partners.
• Commercial Strategy & Operations - Plan smarter co-launches and regional strategies.
• Legal & Contracts Teams - Benchmark clauses and strengthen negotiation positions with real contract language.
• C-Level Executives & Investors - Assess monetization strategies and partnership dynamics in commercial-stage assets.

Due Diligence Made Easy: What You'll Learn from Contracts

By reviewing actual deal agreements, you can evaluate key aspects such as:

• What rights are granted or optioned?
• How is revenue shared and audited?
• What exclusivity and territory provisions are included?
• Who handles commercialization, manufacturing, and supply?
• What is the term and how is termination managed?
• How are disputes, confidentiality, and publication handled?
• Which legal jurisdiction is used?
• Are sublicensing and subcontracting allowed?
• Which clauses are standardized, and which vary across partners?
• Why This Report Matters
• Co-promotion and co-marketing strategies have become vital for maximizing commercial potential, especially in competitive or specialty-driven markets. This report delivers critical intelligence on how industry leaders are structuring these deals-giving you a clear path to negotiate better terms, avoid common pitfalls, and select the right partners.
• Get ahead of your next deal. Explore the data. Learn from the contracts. Make better decisions.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

• 2.1. Introduction
• 2.2. Definition of co-promotion and co-marketing deals
• 2.3. Trends in co-promotion and co-marketing deals since 2016
  • 2.3.1. Co-promotion and co-marketing dealmaking by year, 2016-2026
  • 2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2016-2026
  • 2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2016-2026
  • 2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2016-2026
  • 2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2016-2026
  • 2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2016-2026
• 2.4. Reasons for entering into co-promotion and co-marketing partnering deals
• 2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

• 3.1. Introduction
• 3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

• 4.1. Introduction
• 4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

• 6.1. Introduction
• 6.2. Co-promotion and co-marketing deals with contracts 2016-2026
• Deal directory
• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-promotion and co-marketing
• Figure 2: Trends in co-promotion and co-marketing deal announcements, 2016-2026
• Figure 3: Co-promotion and co-marketing deals signed at each phase of development, 2016-2026
• Figure 4: Co-promotion and co-marketing deals by industry sector, 2016-2026
• Figure 5: Co-promotion and co-marketing deals by therapy area, 2016-2026
• Figure 6: Co-promotion and co-marketing deals by technology type, 2016-2026
• Figure 7: Top 25 most active co-promotion and co-marketing dealmakers, 2016-2026
• Figure 8: Top co-promotion and co-marketing deals by value, 2016-2026
• Figure 9: Most active co-promotion and co-marketing dealmakers, 2016-2026